Efficacy and Safety of Neihulizumab (AbGn-168H) in Patients with Active Psoriatic Arthritis: 24-week Results from a Phase II Open Label Study Cohen, S., Fiechtner, J., Mease, P., Kaine, J., Kavanaugh, A., Cheng, Y., Chou, C., Cheng, T., Lin, S., Genovese, M. WILEY. 2020

View details for Web of Science ID 000587568502132